Personalis (NASDAQ:PSNL) Price Target Raised to $7.25 at Needham & Company LLC

Personalis (NASDAQ:PSNL - Get Free Report) had its price objective raised by analysts at Needham & Company LLC from $5.50 to $7.25 in a note issued to investors on Friday, Benzinga reports. The firm currently has a "buy" rating on the stock. Needham & Company LLC's price objective would suggest a potential upside of 24.36% from the stock's current price.

Separately, Lake Street Capital assumed coverage on Personalis in a research note on Tuesday, April 30th. They issued a "buy" rating and a $4.00 price objective for the company.

View Our Latest Analysis on PSNL

Personalis Stock Performance

Shares of NASDAQ:PSNL traded up $0.76 on Friday, hitting $5.83. The stock had a trading volume of 4,918,409 shares, compared to its average volume of 655,506. Personalis has a twelve month low of $0.89 and a twelve month high of $7.20. The firm's 50 day moving average price is $2.26 and its 200-day moving average price is $1.71. The company has a market capitalization of $309.46 million, a price-to-earnings ratio of -3.14 and a beta of 1.85.

Personalis (NASDAQ:PSNL - Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.34) by $0.10. Personalis had a negative net margin of 101.78% and a negative return on equity of 56.87%. The firm had revenue of $22.58 million for the quarter, compared to the consensus estimate of $19.81 million. During the same period last year, the company posted ($0.50) EPS. As a group, sell-side analysts predict that Personalis will post -1.17 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC grew its holdings in shares of Personalis by 6.7% in the second quarter. Acadian Asset Management LLC now owns 1,057,956 shares of the company's stock worth $1,237,000 after acquiring an additional 66,128 shares during the period. ARK Investment Management LLC raised its position in Personalis by 4.9% during the second quarter. ARK Investment Management LLC now owns 6,361,886 shares of the company's stock valued at $7,443,000 after purchasing an additional 296,413 shares during the period. Virtu Financial LLC bought a new position in shares of Personalis during the first quarter valued at approximately $41,000. Jacobs Levy Equity Management Inc. grew its stake in shares of Personalis by 144.7% during the first quarter. Jacobs Levy Equity Management Inc. now owns 821,657 shares of the company's stock valued at $1,224,000 after buying an additional 485,822 shares during the last quarter. Finally, Public Employees Retirement System of Ohio bought a new position in Personalis in the first quarter worth approximately $29,000. Hedge funds and other institutional investors own 61.91% of the company's stock.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.

Featured Articles

• Five stocks we like better than Personalis
• What is an Earnings Surprise?
• JD.com Earnings Surprise: China’s Outlook Better Than Expected
• Insider Buying Explained: What Investors Need to Know
• Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch
• What Are Some of the Best Large-Cap Stocks to Buy?
• Sea Limited’s E-Commerce and Fintech Strength Fuel Stock Surge

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Personalis right now?

Before you consider Personalis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Personalis wasn't on the list.

While Personalis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here